All Square Wealth Management LLC Anavex Life Sciences Corp. Call Options Transaction History

All Square Wealth Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 11, 2021	SELL	$5.17 - $16.13 $2,068 - $6,452	-400 Reduced 57.14%	300 $4,000
Q4 2019 Feb 04, 2020	BUY	$2.31 - $3.14 $924 - $1,256	400 Added 133.33%	700 $2,000
Q2 2019 Aug 13, 2019	BUY	$2.75 - $3.7 $825 - $1,110	300 New	300 $1,000

159

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $327M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of All Square Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on All Square Wealth Management LLC with notifications on news.